1,161
Views
1
CrossRef citations to date
0
Altmetric
Research Article

A novel phenolic propanediamine moiety-based lung-targeting therapy for asthma

, , , &
Pages 1117-1126 | Received 14 Feb 2018, Accepted 01 May 2018, Published online: 21 May 2018

References

  • Balyasnikova IV, Yeomans DC, McDonald TB, Danilov SM. (2002). Antibody-mediated lung endothelium targeting: in vivo model on primates. Gene Ther 9:282–90.
  • Barnes PJ. (2010). New therapies for asthma: is there any progress? Trends Pharmacol Sci 31:335–43.
  • Bend JR, Serabjit-Singh CJ, Philpot RM. (1985). The pulmonary uptake, accumulation, and metabolism of xenobiotics. Annu Rev Pharmacol Toxicol 25:97–125.
  • Cao F, Ding B, Sun M, et al. (2011). Lung-targeted delivery system of curcumin loaded gelatin microspheres. Drug Deliv 18:545–54.
  • Cutler MJ, Choo EF. (2011). Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments. Curr Drug Metab 12:793–807.
  • Dunford PJ, Holgate ST. (2010). The role of histamine in asthma. Adv Exp Med Biol 709:53–66.
  • Gao Y, Chen X, Fang L, et al. (2014). Rhein exerts pro- and anti-inflammatory actions by targeting IKKbeta inhibition in LPS-activated macrophages. Free Radic Biol Med 72:104–12.
  • Gazdar AF, Carney DN, Russell EK, et al. (1980). Establishment of continuous, clonable cultures of small-cell carcinoma of the lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res 40:3502–7.
  • Grancara S, Martinis P, Manente S, et al. (2014). Bidirectional fluxes of spermine across the mitochondrial membrane. Amino Acids 46:671–9.
  • Inhaler Error Steering C, Price D, Bosnic-Anticevich S, et al. (2013). Inhaler competence in asthma: common errors, barriers to use and recommended solutions. Respir Med 107:37–46.
  • Keenan CR, Salem S, Fietz ER, et al. (2012). Glucocorticoid-resistant asthma and novel anti-inflammatory drugs. Drug Discov Today 17:1031–8.
  • Li N, Weng D, Wang SM, et al. (2017). Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury. Drug Deliv 24:1770–81.
  • Long AA. (2011). The burden of asthma and improving patient outcomes. Am J Manag Care 17:S75–S81.
  • Lu H, Li J, Li M, et al. (2015). Systemic delivery of alpha-asarone with Kolliphor HS 15 improves its safety and therapeutic effect on asthma. Drug Deliv 22:266–75.
  • Lyer AK, Khaled G, Fang J, Maeda H. (2006). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today 11:812–18.
  • Miniati M, Paci A, Cocci F, et al. (1996). Mitochondria act as a reservoir for the basic amine HIPDM in the lung. Eur Respir J 9:2306–12.
  • Moerlein SM, Lannoye GS, Welch MJ. (1990). No-carrier-added radiosynthesis of [123I]HIPDM: N,N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-[123I]iodobenzyl)-1,3-propanediamine. Int J Rad Appl Instrum A 41:253–7.
  • Okura T, Hattori A, Takano Y, et al. (2008). Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone. Drug Metab Dispos 36:2005–13.
  • Pelaia G, Vatrella A, Maselli R. (2012). The potential of biologics for the treatment of asthma. Nat Rev Drug Discov 11:958–72.
  • Shi S, Han L, Gong T, et al. (2013). Systemic delivery of microRNA-34a for cancer stem cell therapy. Angew Chem Int Ed Engl 52:3901–5.
  • Shi S, Zhou M, Li X, et al. (2016). Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies. J Control Release 235:1–13.
  • Shih W-J, Coupal JJ, Dillon ML, Kung HF. (1988). Application of I-123 HIPDM as a lung imaging agent. Eur J Nucl Med 14:21–4.
  • Singh B, Nadkarni JR, Vishwakarma RA, et al. (2012). The hydroalcoholic extract of Cassia alata (Linn.) leaves and its major compound Rhein exhibits antiallergic activity via mast cell stabilization and lipoxygenase inhibition. J Ethnopharmacol 141:469–73.
  • Spangler DL. (2012). The role of inhaled corticosteroids in asthma treatment: a health economic perspective. Am J Manag Care 18: S35–S9.
  • Taguchi C, Inazu M, Saiki I, et al. (2014). Functional analysis of [methyl-(3)H]choline uptake in glioblastoma cells: influence of anti-cancer and central nervous system drugs. Biochem Pharmacol 88:303–12.
  • Teicher BA, Chari RV. (2011). Antibody conjugate therapeutics: challenges and potential. Clin Cancer Res 17:6389–97.
  • Vega-Villa KR, Takemoto JK, Yanez JA, et al. (2008). Clinical toxicities of nanocarrier systems. Adv Drug Deliv Rev 60:929–38.
  • Zhou M, Li J, Li C, et al. (2016). Tertiary amine mediated targeted therapy against metastatic lung cancer. J Control Release 241:81–93.